Michigan Cancer Consortium

Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

Cancer Biology Graduate Program’s Allison Mitchell wins 2020 Leonard N. Simons Award

Allison Mitchell, a doctoral candidate in the Cancer Biology Graduate Program at Karmanos Cancer Institute and Wayne State University School of Me...

Read More

Understanding blood cancers

Blood cancer encompasses many kinds of hematologic malignancies, including but not limited to leukemia. September is National Blood Cancer Awarene...

Read More

Prostate Cancer Awareness Month: A Q&A with Elisabeth Heath, M.D., FACP

The prostate is a walnut-sized organ located behind the bladder. It is part of the male reproductive system and is not present in women. Prostate ...

Read More